Search
for
Sort by
Research 721–750 of 1000+
- Features of the immune status and comorbidities in children with alopecia areata
- Alopecia areata
- Alopecia areata multifocal grave – Um caso imagiológico
- Effectiveness of oral tofacitinib treatment on patients with moderate‐to‐severe alopecia areata in Iran
- Exosomes derived from uMSCs promote hair regrowth in alopecia areata through accelerating human hair follicular keratinocyte proliferation and migration
- Alopecia Areata with Renal Dysgenesis
- 253 Frontal fibrosing alopecia: clinical and therapeutic considerations - case series
- Association between Alopecia Areata and Thyroid Dysfunction
- Targetoid Hair Regrowth Pattern in Alopecia Areata: A Case Series
- Melan-A Positive cells significantly expressed in immune-targeted follicles of Alopecia Areata
- ALOPECIA AND ITS AYURVEDIC MANAGEMENT: A CASE REPORT
- The pharmacological treatment of alopecia areata
- Practical Approach for Treatment lines of Alopecia Areata: Review Article
- Thionamide-Responsive Alopecia Areata in a 11 Year Girl
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Tofacitinib: A Promising Treatment for Adolescent Alopecia Areata
- CD4+ Treg expansion arrests disease progression in a pre-clinical model of alopecia areata
- Review of efficacy of baricitinib in the treatment of alopecia areata
- 1373 Expression of programmed cell death 1 inversely correlated with the density of CD8+ T cells infiltrating hair follicles in alopecia areata
- 148 Decreased IL-10 producing regulatory B cells in patients with alopecia areata
- Viral-Induced Rapidly Progressive Alopecia Universalis: A Case Report and Literature Review
- Alopecia Areata: A Case Report
- A Precis of the alopecia (Hair loss) associated with therapies based on nanotechnology and its impact on quality of Life (QoL)
- Individualized homoeopathic approach in Alopecia Areata: An evidence-based case report
- Evaluation of some biochemical markers in alopecia areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Alemtuzumab-Induced Secondary Autoimmune Skin Disorders as Side Effects of Multiple Sclerosis Therapy: Problem That Can Be Influenced or Fate? A Narrative Overview of The Literature A Neuroprotective Role of Vitamin D?
- Tofacitinib in a Recalcitrant Case of Alopecia Areata
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura